Related Experiment Video
Updated: Jun 26, 2026

A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
Published on: September 22, 2023
[Problems and prospects of care for newborn babies with an extremely low body weight]
Insights
Children born at extremely low birth weight (500-999g) often face severe disabilities. New neuroprotective therapies and integrated treatments are crucial for reducing these health issues in vulnerable infants.
Area of Science:
- Neonatal care and developmental pediatrics.
- Perinatology and intensive neonatal medicine.
Context:
- Focuses on the long-term outcomes for extremely low birth weight (ELBW) infants (500-999g).
- Highlights the high incidence of severe somato-neurologic pathology and disability in ELBW survivors despite current interventions.
Purpose:
- To discuss the challenges in morbidity, treatment, rehabilitation, and follow-up for ELBW children.
- To identify areas for improvement in managing health conditions in this high-risk population.
Summary:
- ELBW infants frequently develop combined pathologies, including nervous system lesions, bronchopulmonary dysplasia, and retinopathy, leading to disability.
- Current rehabilitation and nursing methods are insufficient to prevent severe, multi-systemic conditions in most ELBW survivors.
Impact:
- Emphasizes the need for novel resuscitation and intensive care strategies.
- Recommends integrating advanced neuroprotective technologies, such as anticytokines and stem cells, with non-medicinal therapies to improve outcomes.
Abstract:
The paper is designed to discuss problems of morbidity, treatment, rehabilitation, and late follow-up development in children of extremely low birth weight (500-999 g). Despite the use of modern methods of rehabilitation and nursing, the overwhelming majority of such children develop severe combined somato-neurologic pathology leading to disability (polymorphic lesions in the nervous system, broncho-pulmonary dysplasia, retinopathy, etc.). Efficacious approach to the reduction of frequency and severity of polysystemic pathological conditions requires improvement and development of new methods of resuscitation and intensive therapy based on up-to-date neuroprotective technologies (including the use of anticytokines and stem cells) and their combination with non-medicamentous therapeutic modalities.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
